Strain Name: gsx2 ; Tg(UAS-hsp70l:mCherry-T2A-CreERT2) / Allele: nub123TgTg(hsp70l-Gal4FF) ; nub99Tg |
|
| Allele | nub123TgTg(hsp70l-Gal4FF) ; nub99Tg |
| Strain Name | gsx2 ; Tg(UAS-hsp70l:mCherry-T2A-CreERT2) |
| Type | Mutant, Transgenic |
| Genotype | |
| Affected Gene | gsx2 |
| Origin and Depositor | Nagoya University (Masahiko Hibi) |
| Link to ZFIN |
| Information | |
|
(gsx2 nub123TgTg(hsp70l-Gal4FF))The hsp70l-Gal4FF-pAS cassette was knocked in gsx2 locus by a CRISPR method. Gal4FF is expressed in cells expressing gsx2. (Tg(UAS-hsp70l:mCherry-T2A-CreERT2) nub99Tg) The expression of mCherry and CreERT2 (inducible Cre recombinase) is driven by UAS (5xGal4 binding sites) and hsp70l promoter in this transgenic line. |
| The Conditions to Distribute Strains | |
|
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, the recipient shall acquire the consent from the DEPOSITOR. The recipient and the DEPOSITOR shall sign an MTA, which set forth the terms and conditions to use the intellectual property rights based on the results of research using the BIOLOGICAL RESOURCE and so on. The recipient shall be sent an agreement for distribution obtained from the DEPOSITOR to NZC. |
| Request |
|
| Reference | |
| Facility | RIKEN Center for Brain Science |